MIKAYLA KISH: Open Payments
NPI 1770253304 · WESCOSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 40 payments from 14 companies in 2025. Trend: 2023 $2,102 · 2024 $1,718 · 2025 $821
Food & beverage: $742Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $157 |
| Lilly USA, LLC | 8 | $151 |
| Astellas Pharma US Inc | 3 | $112 |
| AstraZeneca Pharmaceuticals LP | 6 | $110 |
| Novo Nordisk Inc | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Exact Sciences Corporation | 1 | $30 |
| Inspire Medical Systems, Inc. | 1 | $24 |
Products named: UBRELVY, JARDIANCE, MOUNJARO, AIRSUPRA, QULIPTA, Ozempic, XIFAXAN, Veozah.
Industry payments across PA — which companies pay providers there.
